| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 13.75 | -6.35 | -26.74 | -48.45 |
| Net Changein Cash | 38.17 | -17.57 | 20.24 | 37.38 |
| Cash Taxes Paid | 83.44 | 109.95 | 145.76 | 184.26 |
| Net Income/ Starting Line | 343.92 | 405.67 | 559.73 | 667.59 |
| Changesin Working Capital | -115.58 | -62.54 | -139.99 | -378.22 |
| Cashfrom Operating Activities | 288.16 | 358.48 | 457.20 | 330.00 |
| Cash Interest Paid | 10.43 | 7.45 | 11.56 | 6.23 |
| Cashfrom Financing Activities | 3.32 | -13.80 | -241.95 | -156.41 |
| Depreciation/ Depletion | 77.49 | 51.81 | 46.46 | 38.26 |
| Other Investing Cash Flow Items Total | -99.59 | -310.47 | 90.91 | -61.02 |
| Capital Expenditures | -155.71 | -51.79 | -285.91 | -75.19 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 1.99 | 0.00 | 0.00 | 0.00 |
| Non- Cash Items | -17.67 | -36.46 | -9.00 | 2.38 |
| Financing Cash Flow Items | -10.43 | -7.45 | -11.56 | -6.14 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -255.30 | -362.25 | -195.01 | -136.21 |
| Total Cash Dividends Paid | - | - | -203.65 | -101.83 |
Cohance Lifesciences Dividend Cohance Lifesciences Bonus Cohance Lifesciences News Cohance Lifesciences AGM Cohance Lifesciences Rights Cohance Lifesciences Splits Cohance Lifesciences Board Meetings Cohance Lifesciences Key Metrics Cohance Lifesciences Shareholdings Cohance Lifesciences Profit Loss Cohance Lifesciences Balance Sheet Cohance Lifesciences Q1 Results Cohance Lifesciences Q2 Results Cohance Lifesciences Q3 Results Cohance Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks